A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

Summary

The purpose of this study is to investigate radiographic progression-free survival (PFS) of enzalutamide in chemotherapy-naïve patients with progressive metastatic castration-resistant prostate cancer who have symptomatic disease.

Timeline

Start

2012-08

Primary completion

2014-10

Completion

2014-10

Outcome

Outcome not reported

Stopped (Business): “A business decision was made to not initiate this study.”

Drugs

Indications